—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Smith & Nephew SNATS Inc (SNN) — chart, structure and Closelooknet read

The Closelooknet read

Smith & Nephew designs and sells medical devices across three areas: joint replacement and trauma implants, sports-medicine tools for minimally invasive joint surgery, and wound-care products for chronic and post-operative wounds. It supplies hospitals and surgeons in the UK, the US and other markets, and is headquartered in Watford, England.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for SNN, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 44/100 · S&P 500 fund at 48, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-05
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 73th percentile of the window, -21.7% over 20 sessions. Factor regime → 2026-11-04
  • Sector × region Health care in US: +0.5% week · +9.5% month · +12.0% quarter · +26.5% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-11-05
  • Sovereign pressure Index -2.05 · down 2.95 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-05
How it trades on rate days beta 0.58 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How SNN has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.58 — tends to move with bonds for every 1% move in TLT (20+ year Treasuries), Smith & Nephew SNATS Inc moved 0.58% on average · correlation 0.19 · higher than 53% of US names
  • Beta, last 3 months 0.86 more rate-sensitive lately than over the year
  • On the 10 worst bond days −1.25% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −0.52% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Devices · US · 8 names with week and year-to-date

Peer group

Medical Devices · US

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against SNN on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Smith & Nephew SNATS Inc

SNN in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Smith & Nephew designs and sells medical devices across three areas: joint replacement and trauma implants, sports-medicine tools for minimally invasive joint surgery, and wound-care products for chronic and post-operative wounds. It supplies hospitals and surgeons in the UK, the US and other markets, and is headquartered in Watford, England.
Where it sits in the stack
Smith & Nephew sits outside our AI build-out universe; it belongs to the Healthcare sector, Medical Devices industry, and does not hold a seat in either of our indices.
Who it is priced against
The comparison the market draws is with other orthopaedic and wound-care device makers such as Stryker, given the overlap in implants and surgical tools.
Why Closelooknet tracks it
It carries no seat in our indices and no peer group from the diary's sort; it holds a score, but with only one module scored so far the read is still being built, and no quotes are on file.
What the diary watches
Whether demand for elective joint procedures and wound-care volumes recovers enough to lift growth across its three segments together.

Smith & Nephew SNATS Inc (SNN) trades on US exchanges, classified under Healthcare.

The Closelooknet company score reads 59/100 composite (momentum 60, quality 56, valuation 70) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 3 analyst actions on the wire · latest: price target by Berenberg, 2026-09-11

The Street on this name

Analyst actions and the latest print for SNN from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Berenberg — target 33.88 from 33.77 Target raised to $33.88 from $33.77 (+23.4% to spot) 2026-09-11
  • Downgrade Morgan Stanley — Overweight → Cautious Downgraded to Cautious from Overweight 2026-09-02
  • Initiation BTIG — at Neutral Initiated to Neutral 2026-08-31

3 actions on the analyst wire since 2026-08-13: 1 downgrade, 1 initiation, 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 2.48%, semi-annual · buybacks 502 m USD in FY2025

Dividends and capital return

What SNN pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.79 USD per share · a 2.48% yield on the 2026-11-05 close 2 distributions, paid twice a year 2026-11-05
  • Change on the year +4.2% against the prior twelve months prior twelve months 0.76 USD per share
  • Last distribution 0.31 USD per share as the price series records it, within days of the ex-date 2026-10-02
  • By calendar year 2025: 0.76 USD (partial) · 2026: 0.79 USD to date first distribution recorded in the three-year window: 2025-03-28
  • Dividends paid, FY2025 330 m USD 2% of earnings
  • Buybacks, FY2025 502 m USD 4.0% of today's market value
  • Share count −0.4% in FY2025 43 m USD of stock-based compensation in the year
  • Capital returned 832 m USD · 98% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-06

Quick answers

What is Smith & Nephew SNATS Inc (SNN)?

Smith & Nephew SNATS Inc trades as SNN on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-06.

Is SNN in a Closelooknet index?

Not currently — Smith & Nephew SNATS Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-06.

What is Smith & Nephew SNATS Inc's Closelooknet composite score?

59 out of 100, with momentum 60, quality 56 and valuation 70 sub-scores, as of 2026-11-06. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does SNN trade against its moving averages?

Smith & Nephew SNATS Inc trades 12.7% above its 50-day and 3.5% above its 200-day moving average (7.9% above its 20-day). As of 2026-11-05 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Smith & Nephew SNATS Inc compare with its peers?

Against its peer group (Medical Devices · US), Smith & Nephew SNATS Inc (SNN) sits 12.4% below its 52-week high, 12.7% above its 50-day average; DexCom Inc (DXCM) is 4.4% below, Globus Medical (GMED) is 14.1% below, Stryker Corporation (SYK) is 13.0% below, as of 2026-11-05. Put any of them next to SNN in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Smith & Nephew SNATS Inc trade when bond yields rise?

Over the past year Smith & Nephew SNATS Inc had a beta of 0.58 to TLT, the long-dated Treasury fund — it tends to move with bonds, higher than 53% of US names. On the 10 sessions in which long bonds fell most it moved −1.25% on average, against −0.74% for the S&P 500. As of 2026-11-05; The "How it trades on rate days" block on this page carries the lines.

What does Smith & Nephew SNATS Inc do?

Smith & Nephew designs and sells medical devices across three areas: joint replacement and trauma implants, sports-medicine tools for minimally invasive joint surgery, and wound-care products for chronic and post-operative wounds. It supplies hospitals and surgeons in the UK, the US and other markets, and is headquartered in Watford, England. The comparison the market draws is with other orthopaedic and wound-care device makers such as Stryker, given the overlap in implants and surgical tools. (Company snapshot of 2026-09-17.)

Where does Smith & Nephew SNATS Inc sit in the AI build-out?

Smith & Nephew sits outside our AI build-out universe; it belongs to the Healthcare sector, Medical Devices industry, and does not hold a seat in either of our indices. It carries no seat in our indices and no peer group from the diary's sort; it holds a score, but with only one module scored so far the read is still being built, and no quotes are on file. (Company snapshot of 2026-09-17.)

Does Smith & Nephew SNATS Inc pay a dividend?

Smith & Nephew SNATS Inc has paid 0.79 USD per share over the last twelve months, paid twice a year, a trailing yield of 2.48% on the 2026-11-05 close; the last distribution recorded in the price series was 0.31 USD on 2026-10-02. In fiscal 2025 the company paid 330 m USD in dividends and bought back 502 m USD of its own shares, 98% of that year’s free cash flow. The share count fell 0.4% over the fiscal year. As of 2026-11-05; the "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Smith & Nephew SNATS Inc recently?

The most recent analyst action on Smith & Nephew SNATS Inc on the Closelooknet wire is a price target by Berenberg on 2026-09-11 (target 33.88 from 33.77). 3 actions on the analyst wire since 2026-08-13: 1 downgrade, 1 initiation, 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for SNN, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.